Stockreport

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates [Yahoo! Finance]

iTeos Therapeutics, Inc.  (ITOS) 
PDF and 1L HNSCC - Completed enrollment of third dose cohort in Phase 1 trial of EOS-984 - Preclinical presentations on role of ENT1 at SITC Spring Scientific and profile of [Read more]